A method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone

Through the nucleophilic addition reaction between nitrojeron and diaryl phosphorus oxide, the problem of adding P(O)-H bond to the unsaturated C=N double bond of nitrojeron is solved, and α-(hydroxyamino) di- The efficient and green synthesis of arylphosphine oxides demonstrates its anti-tumor activity and low cytotoxicity, and is suitable as an anti-tumor drug intermediate.

CN115583970BActive Publication Date: 2024-11-26NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211267152.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-17
Publication Date
2024-11-26
Estimated Expiration
2042-10-17

AI Technical Summary

Technical Problem

The prior art lacks efficient, economical and environmentally friendly methods for adding P(O)-H bonds to the unsaturated C=N double bond of nitroster, which limits the structural diversity and industrial production of organophosphorus oxides, and α- Research on the anti-tumor activity of (hydroxyamino)phosphine oxides has not yet been thorough.

Method used

Nucleophilic addition reaction is carried out under heating conditions by using nitrosterone and diarylphosphine oxide. By controlling the reaction conditions and solvent selection, the efficient synthesis of α-(hydroxyamino)diarylphosphine oxide is achieved, and this method does not require a catalyst. , suitable for industrial production.

Benefits of technology

The high yield, green and environmentally friendly synthesis of α-(hydroxyamino)diarylphosphine oxide is achieved, with good anti-tumor activity and low cytotoxicity, and is suitable as an intermediate for anti-tumor drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115583970B_ABST
    Figure CN115583970B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of medical technology, and relates to a method for preparing α-(hydroxyamino) diarylphosphine oxide from nitrone. The present invention uses nitrone and diarylphosphine oxide as raw materials under mild conditions to establish a simple, catalyst-free method for synthesizing α-(hydroxyamino) phosphine oxide. The reaction of the present invention can be reacted in the absence of solvent or in a low-addition solvent, and the reaction atom economy is high. It can be purified by a simple recrystallization method, and exhibits a wide range of substrates and good functional group tolerance, and has the characteristics of cheap and easy raw materials, high yield, simple operation, high safety, no pollution, a wide range of substrate applications, and is suitable for industrial production. Pharmacological activity experiments show that the compounds have good anti-cancer activity, no obvious cytotoxicity, potential medicinal value, and are expected to be used in the preparation of various anticancer drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of medical technology, and specifically relates to a method for preparing alpha-(hydroxyamino)diarylphosphine oxide from nitrone. Background Art

[0002] Organophosphorus compounds are important compounds in organic synthesis and are of considerable importance in the fields of pharmaceutical chemistry, agroindustry, etc., such as pharmaceuticals (antiviral and anticancer agents), agrochemicals (pesticides and herbicides), catalytic ligands and industrial additives (e.g., polymers and flame retardants). The classical synthesis of these compounds is affected by the use of stoichiometric additives, the need for protecting groups, and the poor tolerance of functional groups. This has prompted the study of adding P(O)-H bonds directly to C=N unsaturated bonds, which has the potential to have 100% atomic efficiency.

[0003] α-(Hydroxyamino)phosphine oxide has not been synthesized in large quantities. It may have unique biological activity and medicinal value, and it can be used as an intermediate for the synthesis of α-aminophosphine compounds, which have antiviral, antibacterial, anticancer and enzyme inhibitory activities. Therefore, as an important class of organic synthesis intermediates, organic phosphorus oxides have important application value in the fields of natural product synthesis, chemical industry, and medicine. The development of green, efficient, and economical methods for the synthesis of organic phosphorus oxides has attracted extensive attention from researchers in related fields.

[0004] In the prior art, methods for adding P(O)-H bonds to olefins or alkynes without adding solvents or catalysts have been studied. The prior art also discloses a catalyst-free, low-solvent method for the hydrophosphonylation of isocyanates and isothiocyanates. However, no one has studied the method for adding P(O)-H bonds to the unsaturated C=N double bond of nitrone. Therefore, it is of great significance to develop an economical, environmentally friendly and efficient synthesis method, which is conducive to increasing the diversity of the structure of organic phosphine compounds.

[0005] Malignant tumors are serious diseases that threaten human health and life, and are one of the main causes of death in China. Finding and discovering new drugs for the treatment and prevention of tumors is also a major issue currently faced. There are no reports on the antitumor activity of α-(hydroxyamino)phosphine oxides. Summary of the invention

[0006] Based on the above technical problems, the purpose of the present invention is to provide a green synthesis method of α-(hydroxyamino)diarylphosphine oxide to prepare a new organophosphorus compound, which has the characteristics of cheap and readily available raw materials, high yield, simple operation, high safety, no pollution, wide substrate application range, and suitability for industrial production.

[0007] The compound prepared by the present invention shows good results in an in vitro anti-tumor activity test and has no obvious cytotoxicity.

[0008] According to a specific embodiment of the present invention, a method for preparing an α-(hydroxyamino)diarylphosphine oxide from a nitrone is provided, wherein a nitrone as shown in formula (2) and a diarylphosphine oxide compound as shown in formula (3) are used as raw materials, and a reaction is carried out under heating conditions to obtain an α-(hydroxyamino)diarylphosphine oxide as shown in formula (1).

[0009]

[0010] Wherein, R1 is selected from C1-C 10 One of an alkyl group, a furyl group, a thienyl group, a C5-C6 alkylene ring, a phenyl group or an aromatic group,

[0011] R2 is selected from C1-C 10 One of an alkyl group, a C5-C6 alkylene ring, and a substituted or unsubstituted phenyl group;

[0012] R3 and R4 are each independently selected from a phenyl group and an aromatic group.

[0013] The term "alkyl" refers to a saturated or unsaturated aliphatic hydrocarbon group, which may be straight or branched and have 1 to 10 atoms in the chain. Preferred alkyl groups have 1 to 6 carbon atoms in the chain. "Branched" refers to one or more lower alkyl groups such as methyl, ethyl or propyl being connected to a linear alkyl chain. "Lower alkyl" refers to having 1 to 4 carbon atoms in the chain, which may be straight or branched. The alkyl group may be substituted with one or more identical or different "alkyl substituents" including, for example, halogen, cycloalkyl, hydroxyl, alkoxy, amino, amide, arylamide, carboxyl.

[0014] According to the method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone in a specific embodiment of the present invention, R1 is selected from ethyl, propyl, isopropyl, butyl, isobutyl, cyclohexyl, halogenated phenyl, alkyl-substituted phenyl, methoxy-substituted phenyl, methylamino-substituted phenyl, acetoxy-substituted phenyl, naphthyl or biphenyl.

[0015] The term "halo" refers to substitution with an atom from the halogen group of the periodic table, and specifically includes fluorine, chlorine, bromine and iodine atoms.

[0016] According to the method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone in a specific embodiment of the present invention, R2 is selected from ethyl, propyl, isopropyl, butyl, isobutyl, cyclohexyl, phenyl or benzyl.

[0017] Preferably, R1 and R2 are each independently selected from a C5-C6 alkylene ring.

[0018] According to the method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone in a specific embodiment of the present invention, any amount of raw materials that can promote the above-mentioned nucleophilic addition reaction is feasible. In order to improve the reaction yield and raw material utilization rate, the ratio of nitrone to diarylphosphine oxide is 1:1-2 based on the molar ratio of substances. Preferably, the ratio of nitrone to diarylphosphine oxide is 1:1.5.

[0019] According to the method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone in a specific embodiment of the present invention, as long as the solvent that can promote the above-mentioned nucleophilic addition reaction does not cause the denaturation of the raw materials and products, the amount of the solvent has a positive effect on the reaction and promotes the reaction, it is feasible. In a certain embodiment, nitrone and diarylphosphine oxide are used as raw materials, and water or n-hexane is used as solvent. Preferably, the amount of water can be 50-100 times the amount of nitrone, and the amount of n-hexane can be 50-100 times the amount of nitrone.

[0020] According to the method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone in a specific embodiment of the present invention, the reaction time is 1-3 hours.

[0021] According to a specific embodiment of the present invention, the method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone is carried out by using nitrone as shown in formula (2) and diarylphosphine oxide compound as shown in formula (3) as raw materials and reacting at a temperature of 60-90°C.

[0022] According to the method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone in a specific embodiment of the present invention, after obtaining the α-(hydroxyamino)diarylphosphine oxide shown in formula (1), it is purified, and the purification steps are: removing the solvent, purifying by recrystallization or pulping to obtain a pure product.

[0023] Preferably, the recrystallization step is: first dissolving the product with ethyl acetate, then precipitating the product with n-hexane, and filtering to obtain a pure product;

[0024] The steps of beating are: firstly, adding n-hexane to the product, stirring rapidly to dissolve the impurities, and then filtering to obtain a pure product.

[0025] In the above preparation method, the recrystallization solvent is composed of 1-5 parts by volume of normal hexane and 1 part by volume of ethyl acetate. Normal hexane can also be replaced with petroleum ether, and the product and other impurities can be effectively separated through recrystallization reaction, and the yield is extremely high.

[0026] The present invention also provides the use of α-(hydroxyamino)diarylphosphine oxide in the preparation of anti-tumor drugs. The drugs include α-(hydroxyamino)diarylphosphine oxide and pharmaceutically acceptable salts of α-(hydroxyamino)diarylphosphine oxide.

[0027] The term "pharmaceutically acceptable salt" refers to a salt that retains the biological effectiveness and properties of the compounds of the present invention and is not undesirable biologically or otherwise. In many instances, the compounds of the present invention can form acid and / or basic salts using the presence of amino and / or carboxyl groups or similar groups. Pharmaceutically acceptable acid addition salts can be prepared from inorganic or organic acids, while pharmaceutically acceptable basic addition salts can be prepared from inorganic or organic bases. For example, the above-mentioned salts include those derived from inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, aminosulfonic acid, phosphoric acid, nitric acid, etc., and organic acids such as acetic acid, propionic acid, succinic acid, glycolic acid, stearic acid, lactic acid, malic acid, tartaric acid, citric acid, ascorbic acid, pamoic acid, maleic acid, hydroxymaleic acid, phenylacetic acid, glutamic acid, benzoic acid, salicylic acid, sulfanilic acid, fumaric acid, methanesulfonic acid and toluenesulfonic acid, etc.

[0028] Wherein, the tumor refers to a solid tumor, including breast cancer, prostate cancer, lung cancer, gastric cancer, liver cancer, etc.

[0029] Beneficial effects of the present invention:

[0030] The invention provides a method for preparing α-(hydroxyamino) diarylphosphine oxide, which comprises mixing an aromatic or aliphatic nitrone derivative with diaryl phosphorus oxide in a solvent and then performing a nucleophilic addition reaction to achieve the synthesis of α-(hydroxyamino) diarylphosphine oxide.

[0031] The preparation method can be carried out in air and in the absence of solvent, and the reaction conditions are mild and easy to control; the obtained raw materials are easily available and the substrate has a wide range of applicability; the reaction process can be carried out in the absence of a catalyst; the reaction has strong specificity, a higher yield can be obtained in a shorter time, and the post-processing is simple, green and environmentally friendly, and suitable for large-scale industrial production. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0033] Figure 1 The schematic diagram is a mechanism diagram for preparing α-(hydroxyamino)diarylphosphine oxide by the method of the present invention. DETAILED DESCRIPTION

[0034] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.

[0035] The reaction formula for preparing α-(hydroxyamino)diarylphosphine oxide according to the present invention is:

[0036] As shown in formula (5):

[0037]

[0038] The reaction mechanism is as follows Figure 1 As shown, initially, the proton on the diarylphosphine oxide 2 is transferred and combined with the oxygen anion on the nitrone 1 to form the intermediate I and the nucleophilic part II, in which N exists as a cation and P exists as an anion. Secondly, the P anion attacks the carbon atom of the carbon-nitrogen double bond in II, causing the overall electron transfer of the carbon-nitrogen double bond to N, generating the desired hydrogen phosphination product 3. In addition, under acidic conditions, it is difficult for the diarylphosphine oxide to undergo proton transfer, inhibiting the formation of the intermediate II and thus inhibiting the reaction. Under alkaline conditions, it is difficult for the nitrone 2 to combine with the proton, inhibiting the formation of the intermediate II, causing the nitrone to exist mainly in the form of 1. Therefore, the positive charge density of the central N atom is small, the electron transfer tendency is insufficient, and the OH - Will surround N + Around, the solvation effect is strong, weakening the N + The electron deficiency of , reduces the attack of P anion on the carbon-nitrogen double bond, inhibiting the formation of product 3. Therefore, the reaction of the present invention is a nucleophilic addition reaction mechanism.

[0039] Example 1 Synthesis of (((Hydroxy)benzylamino)(phenyl)methyl)diphenylphosphine oxide (Compound 1).

[0040] The structural formula of compound 1 is:

[0041]

[0042] Method 1 The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-benzyl-α-phenylnitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the temperature (60° C.) is reacted for 2 hours, and the reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 93%.

[0043] Method 2 The synthesis process is as follows: in a round-bottom flask with a volume of 25 ml, N-benzyl-α-phenylnitrone (0.001 mol), diphenylphosphine (0.0015 mol), and water (10 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer. The reaction temperature (90°C) is reacted for 4 hours, and the reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is extracted with 50 ml × 3 ethyl acetate for three times, the organic layer is separated and combined, the organic phase is dried with anhydrous sodium sulfate, filtered, and the filtrate is decompressed and distilled to remove the solvent to obtain the initial product. Then the initial product is purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 93%.

[0044] Method 3 The synthesis process is as follows: In a round-bottom flask with a volume of 10 ml, N-benzyl-α-phenylnitrone (0.001 mol) and diphenylphosphine (0.002 mol) are added in sequence, the temperature (65°C) is such that the reactants are in a molten state, the reaction is carried out for 2 hours, and the reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 94%.

[0045] In the actual synthesis process, the synthesis method can be reasonably selected based on the reaction amount, cost, difficulty of operation, whether the reaction is green, reaction yield, etc.

[0046] The structure of compound 1 was detected by nuclear magnetic resonance, and the results are as follows:

[0047] 1 H NMR (400MHz, CDCl3) δ7.86 (t, J=9.2Hz, 2H), 7.50 (ddt, J=25.1, 19.5, 8.5Hz, 7H), 7.38–6.98 (m,11H),6.72(s,1H),4.64(d,J=7.2Hz,1H),4.10(d,J=13.1Hz,1H),3.64(d,J=13.2Hz,1H). 13C NMR (101MHz, CDCl3) δ136.59,131.43,131.32,131.23,130.99,130.91,129.10 ,128.21,128.09,128.04,127.88,127.77,127.16,77.16,76.84,76.53,61.20.

[0048] Example 2 Synthesis of (((Hydroxy)benzylamino)(2-naphthyl)methyl)diphenylphosphine oxide (Compound 2)

[0049] The structural formula of compound 2 is:

[0050]

[0051] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-benzyl-α-(2-naphthyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 4 hours. The reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 92%.

[0052] The structure of compound 2 was detected by nuclear magnetic resonance, and the results are as follows:

[0053] 1 H NMR (400MHz, CDCl3) δ7.93–7.85(m,3H),7.80–7.76(m,2H),7.74–7.67(m,2H),7.63(dd,J=8.5,1.6Hz,1H),7.60–7.54(m,2H),7.52 –7.43(m,8H),7.25–7.23(m,2H),7.12(dt,J=7.3,2.4Hz,3H),4.80(d,J=7.4Hz,1H),4.09(d,J=13.2Hz,1H),3.63(d,J=13.2Hz,1H). 13C NMR (101MHz, CDCl3) δ136.92,133.10,132.96,132.70,132.68,131.77,131.75,131.67,131. 60,131.58,131.38,131.31,131.27,131.19,130.87,130.76,129.41,129.34,129.12,129.08 ,128.95,128.75,128.55,128.43,128.36,128.25,128.22,128.10,127.99,127.70,127.66,127.60,127.49,127.46,126.58,126.37,126.08,125.99,77.48,77.16,76.84,61.56,61.45.

[0054] Example 3 Synthesis of (((Hydroxy)benzylamino)(cyclohexyl)methyl)diphenylphosphine oxide (Compound 3).

[0055] The structural formula of compound 3 is:

[0056]

[0057] The synthesis process is as follows: in a round-bottom flask with a volume of 25 ml, N-benzyl-α-cyclohexyl nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and water (10 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (90° C.) is maintained for 3 hours. The reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is extracted with 50 ml×3 ethyl acetate for three times, the organic layer is separated and combined, the organic phase is dried with anhydrous sodium sulfate, filtered, and the filtrate is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 95%.

[0058] The structure of compound 3 was detected by nuclear magnetic resonance, and the results are as follows:

[0059] 1H NMR(400MHz, CDCl3)δ7.68(tdd,J=8.4,4.6,1.5Hz,1H),7.62–7.56(m,3H),7.46(t d,J=7.2,1.6Hz,2H),7.41–7.35(m,5H),7.06(dd,J=5.1,2.1Hz,1H),6.35(d,J=7. 4Hz,1H),4.73(s,2H),2.86(tdt,J=11.1,7.4,3.7Hz,1H),1.77–1.69(m,2H),1.58 –1.53(m,2H),1.27–1.16(m,2H),1.15–1.08(m,1H),1.01(qd,J=11.7,3.4Hz,3H). 13 C NMR (101MHz, CDCl3) δ143.37,137.66,133.26,132.67,132.64,131.97,131.7 3,131.31,131.21,131.13,131.04,130.96,130.83,130.72,129.10,129.04, 128.95,128.92,128.83,128.64,128.57,128.52,128.46,128.43,128.21,127.24,77.48,77.16,76.84,69.38,35.09,28.83,26.76,26.13,25.99,25.28.

[0060] Example 4 Synthesis of (((Hydroxy)benzylamino)(2-furanyl)methyl)diphenylphosphine oxide (Compound 4)

[0061] The structural formula of compound 4 is:

[0062]

[0063] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(2-furan)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a recrystallization method (solvent: petroleum ether / ethyl acetate, 70:30) to obtain a pure product. The yield was 91%.

[0064] The structure of compound 4 was detected by NMR, and the results are as follows:

[0065] 1H NMR (400MHz, CDCl3) δ7.67–7.60(m,2H),7.50–7.30(m,7H),7.27–7.14(m,6H),7.10–7.01(m,2H),6.61(t,J=2 .6Hz,1H),6.25(dd,J=3.3,1.9Hz,1H),4.73(d,J=11.1Hz,1H),4.07(d,J=12.6Hz,1H),3.58(d,J=12.7Hz,1H). 13 C NMR (101MHz, CDCl3) δ144.85,144.80,142.48,142.46,136.15,131.67,131.64,131.63,131.60,131.33,131.24,130.83,130 .78,130.69,129.84,129.41,128.27,128.15,128.09,127.97,127.31,113.52,113.48,110.76,77.16,76.84,76.52,61.45.

[0066] Example 5 Synthesis of (((Hydroxy)benzylamino)(4-fluorophenyl)methyl)diphenylphosphine oxide (Compound 5)

[0067] The structural formula of compound 5 is:

[0068]

[0069] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-fluorophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 3 hours. The reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: petroleum ether / ethyl acetate, 80:20) to obtain a pure product. The yield is 82%.

[0070] The structure of compound 5 was detected by nuclear magnetic resonance, and the results are as follows:

[0071] 1H NMR (400MHz, CDCl3) δ7.86–7.78(m,2H),7.56(td,J=7.3,1.5Hz,1H),7.52–7.28(m,8H),7.27–7.19(m,5H),7.12–7. 05(m,2H),6.93(t,J=8.6Hz,2H),6.72(s,1H),4.59(d,J=7.6Hz,1H),4.06(d,J=13.1Hz,1H),3.58(d,J=13.1Hz,1H). 13 C NMR (101MHz, CDCl3) δ136.35,133.25,133.18,131.51,131.34,131.29,131.21,130.89,130.80,129.07 ,128.25,128.13,128.09,128.01,127.89,127.26,114.96,114.75,77.16,76.84,76.52,61.17,61.05.

[0072] Example 6 Synthesis of (((Hydroxy)benzylamino)(4-chlorophenyl)methyl)diphenylphosphine oxide (Compound 6)

[0073] The structural formula of compound 6 is:

[0074]

[0075] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-chlorophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: petroleum ether / ethyl acetate, 80:20) to obtain a pure product. The yield was 84%.

[0076] The structure of compound 6 was detected by NMR, and the results are as follows:

[0077] 1H NMR (400MHz, CDCl3) δ7.87–7.81(m,2H),7.59(td,J=7.3,1.5Hz,1H),7.53–7.41(m,6H),7.36(td,J=7.3,1.4Hz,1H),7. 30–7.22(m,7H),7.13–7.04(m,2H),6.69(s,1H),4.61(d,J=7.6Hz,1H),4.08(d,J=13.1Hz,1H),3.60(d,J=13.1Hz,1H). 13 C NMR (101MHz, CDCl3) δ132.82,132.75,131.58,131.50,131.31,131.22,130.90,130.82,12 9.10,128.30,128.18,128.14,128.10,127.98,127.34,77.16,76.84,76.53,61.21,61.10.

[0078] Example 7 Synthesis of (((Hydroxy)benzylamino)(4-bromophenyl)methyl)diphenylphosphine oxide (Compound 7)

[0079] The structural formula of compound 7 is:

[0080]

[0081] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-bromophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a recrystallization method (solvent: petroleum ether / ethyl acetate, 80:20) to obtain a pure product. The yield was 84%.

[0082] The structure of compound 7 was detected by NMR, and the results are as follows:

[0083] 1H NMR(400MHz, CDCl3)δ7.85–7.78(m,2H),7.56(td,J=7.3,1.5Hz,1H),7.51–7.45(m,2H),7.44–7.31(m,7H),7.27–7 .20(m,5H),7.11–7.03(m,2H),6.72(s,1H),4.58(d,J=7.6Hz,1H),4.05(d,J=13.1Hz,1H),3.58(d,J=13.1Hz,1H). 13 C NMR (101MHz, CDCl3) δ136.19,133.11,133.05,131.58,131.48,131.30,131.21,131.03,130.89,130.80,13 0.06,129.09,128.28,128.16,128.12,128.10,127.98,127.32,122.48,77.16,76.84,76.53,61.21,61.10.

[0084] Example 8 Synthesis of (((Hydroxy)benzylamino)(4-(trifluoromethyl)phenyl)methyl)diphenylphosphine oxide (Compound 8)

[0085] The structural formula of compound 8 is:

[0086]

[0087] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-(trifluoromethyl)phenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a recrystallization method (solvent: petroleum ether / ethyl acetate, 80:20) to obtain a pure product. The yield was 85%.

[0088] The structure of compound 8 was detected by nuclear magnetic resonance, and the results are as follows:

[0089] 1H NMR (400MHz, CDCl3) δ7.76 (ddd, J=11.4, 8.3, 1.4Hz, 2H), 7.50 (td, J=8.0, 7 .4,1.4Hz,3H),7.41(ddt,J=6.6,5.2,2.1Hz,4H),7.36–7.28(m,2H),7.24(t d,J=7.4,1.5Hz,1H),7.19–7.10(m,5H),7.01(dd,J=7.4,2.2Hz,2H),6.71(s ,1H),4.58(d,J=7.3Hz,1H),3.99(d,J=13.1Hz,1H),3.50(d,J=13.2Hz,1H). 13 C NMR (101MHz, CDCl3) δ136.50,135.78,132.72,132.10,132.04,131.96,131.93,13 1.86,131.83,131.72,131.64,131.56,131.27,131.16,131.08,130.54,130.29,1 30.22,129.40,128.63,128.51,128.46,128.41,128.30,127.68,125.46,125.00,124.96,124.92,122.75,77.48,77.36,77.16,76.84,69.11,68.23,61.76,61.65.

[0090] Example 9 Synthesis of (((Hydroxy)benzylamino)(3-chlorophenyl)methyl)diphenylphosphine oxide (Compound 9)

[0091] The structural formula of compound 9 is:

[0092]

[0093] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(3-chlorophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a recrystallization method (solvent: petroleum ether / ethyl acetate, 80:20) to obtain a pure product. The yield was 84%.

[0094] The structure of compound 9 was detected by NMR, and the results are as follows:

[0095] 1H NMR (400MHz, CDCl3) δ7.90–7.83(m,2H),7.60(td,J=7.4,1.7Hz,1H),7.54–7.42(m,6H),7.36(td,J=7.4,1.6Hz,1H),7.31 –7.23(m,6H),7.22–7.13(m,3H),7.12–6.74(m,1H),4.62(d,J=7.1Hz,1H),4.13(d,J=13.2Hz,1H),3.64(d,J=13.2Hz,1H). 13 C NMR (101MHz, CDCl3) δ136.31,133.62,133.37,132.51,131.49,131.47,131.40,131.37,131.27,131.21,131.18,131.03,130.88,130.80,13 0.05,129.61,129.55,129.09,129.01,128.23,128.18,128.17,128.1 1,128.05,127.98,127.86,127.22,77.16,76.84,76.52,61.39,61.28.

[0096] Example 10 Synthesis of (((Hydroxy)benzylamino)(3-fluorophenyl)methyl)diphenylphosphine oxide (Compound 10)

[0097] The structural formula of compound 10 is:

[0098]

[0099] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(3-fluorophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60° C.) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield was 87%.

[0100] The structure of compound 10 was detected by NMR, and the results are as follows:

[0101] 1H NMR (400MHz, CDCl3) δ7.90–7.82(m,2H),7.62–7.58(m,1H),7.57–7.43(m,5H),7.36(td,J=7.3,1.5Hz,1H),7.27(tq,J=10.8,3. 7Hz,8H),7.13(dd,J=7.2,2.4Hz,2H),7.01–6.94(m,1H),4.63(d,J=7.4Hz,1H),4.12(d,J=13.1Hz,1H),3.65(d,J=13.1Hz,1H). 13 C NMR (101MHz, CDCl3) δ136.63,133.93,132.88,132.72,131.88,131.85,131.74 ,131.72,131.62,131.53,131.38,131.23,131.15,130.89,130.78,130.40,129 .56,129.48,129.42,129.09,128.97,128.59,128.47,128.42,128.33,128.22,127.60,118.84,118.77,118.56,115.53,115.31,77.48,77.16,76.84,61.66.

[0102] Example 11 Synthesis of (((Hydroxy)benzylamino)(2-bromophenyl)methyl)diphenylphosphine oxide (Compound 11) The structural formula of Compound 11 is:

[0103]

[0104] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(2-bromophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60° C.) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield was 85%.

[0105] The structure of compound 11 was detected by nuclear magnetic resonance, and the results are as follows:

[0106] 1H NMR(400MHz, CDCl3)δ8.33(d,J=7.9Hz,1H),8.05(ddd,J=11.3,8.1,1.6Hz,2H),7.66–7.51(m,6H),7.45–7.42(m,1H),7.36– 7.31(m,2H),7.26(td,J=5.1,4.7,2.2Hz,6H),7.11(t,J=7.7Hz,1H),6.71(s,1H),5.57(d,J=6.0Hz,1H),3.97–3.87(m,2H). 13 C NMR (101MHz, CDCl3) δ137.43,133.68,133.64,133.41,132.38,132.30,1 31.72,131.69,131.53,131.50,131.40,131.38,131.29,131.14,131.05 ,129.81,129.79,129.02,128.60,128.48,128.05,127.98,127.86,127. 50,127.48,127.15,126.25,126.16,77.43,77.11,76.79,62.20,62.08.

[0107] Example 12 Synthesis of (((Hydroxy)benzylamino)(4-nitrophenyl)methyl)diphenylphosphine oxide (Compound 12)

[0108] The structural formula of compound 12 is:

[0109]

[0110] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-nitrophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60° C.) was reacted for 4 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield was 83%.

[0111] The structure of compound 12 was detected by nuclear magnetic resonance, and the results are as follows:

[0112] 1H NMR (400MHz, CDCl3) δ8.07(d,J=8.4Hz,2H),7.87–7.81(m,2H),7.64(d,J=8.3Hz,2H),7.58(dd,J=7.5,1.6Hz,1H),7.49(td,J=7.6,3.1Hz,2H),7.44– 7.36(m,3H),7.33(dd,J=7.5,1.6Hz,1H),7.28–7.22(m,5H),7.12–7.07(m, 2H), 4.72 (d, J = 7.0Hz, 1H), 4.07 (d, J = 13.1Hz, 1H), 3.59 (d, J = 13.1Hz, 1H). 13 C NMR (101MHz, CDCl3) δ147.60,139.45,136.12,132.52,132.46,131.99,131.97,131.94,131.91,131.50,131.41,131.00,1 30.92,129.33,128.59,128.47,128.44,128.41,128.32,127.71,122.96,77.40,77.08,76.76,68.82,67.95,61.97,61.86.

[0113] Example 13 Synthesis of (((Hydroxy)benzylamino)(2-chlorophenyl)methyl)diphenylphosphine oxide (Compound 13)

[0114] The structural formula of compound 13 is:

[0115]

[0116] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(2-chlorophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60° C.) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield was 84%.

[0117] The structure of compound 13 was detected by nuclear magnetic resonance, and the results are as follows:

[0118] 1H NMR (400MHz, CDCl3) δ8.27(d,J=7.8Hz,1H),7.97(ddd,J=11.3,8.2,1.5Hz,2H),7.59(dd,J=7.2,1.6Hz,1H),7.57–7.51(m,3H),7.50– 7.48(m,1H),7.35–7.30(m,1H),7.29–7.20(m,7H),7.17(dt,J=8.6,5.1Hz,3H),6.59(s,1H),5.49(d,J=6.5Hz,1H),3.96–3.76(m,2H). 13 C NMR (101MHz, CDCl3) δ137.32,133.71,133.68,133.40,132.68,132.40,131.84,1 31.81,131.65,131.63,131.48,131.39,131.10,131.01,130.89,130.77,130.48 ,130.38,129.63,129.61,129.38,129.13,129.07,128.96,128.67,128.55,128.14,128.12,128.00,127.28,126.95,126.93,77.48,77.16,76.84,62.28,62.16.

[0119] Example 14 Synthesis of (((Hydroxy)benzylamino)(2,6-dichlorophenyl)methyl)diphenylphosphine oxide (Compound 14)

[0120] The structural formula of compound 14 is:

[0121]

[0122] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(2,6-dichlorophenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield was 81%.

[0123] The structure of compound 14 was detected by NMR, and the results are as follows:

[0124] 1H NMR (400MHz, CDCl3) δ8.17–8.07(m,2H),7.72–7.64(m,2H),7.57(dt,J=6.1,2.6Hz,3H),7.46–7.40(m,2H),7.36–7.22( m,7H),7.13(dd,J=8.0,1.3Hz,1H),7.03(td,J=8.0,1.5Hz,1H),6.70(s,1H),6.09(d,J=4.2Hz,1H),3.92–3.76(m,2H). 13 C NMR (101MHz, CDCl3) δ137.34,136.82,136.78,136.19,136.12,135.60,134. 59,131.51,131.28,131.26,131.14,131.11,130.99,130.97,130.90,130.8 8,130.14,130.12,129.43,129.40,128.86,128.41,128.30,127.83,127.77,127.30,127.18,126.89,77.16,76.84,76.53,71.22,70.38,62.43,62.32.

[0125] Example 15 Synthesis of (((Hydroxy)benzylamino)(4-methylphenyl)methyl)diphenylphosphine oxide (Compound 15)

[0126] The structural formula of compound 15 is:

[0127]

[0128] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-methylphenyl)nitrone (0.001 mol) and diphenylphosphine (0.002 mol) were added in sequence, and the temperature (65°C) was such that the reactants were in a molten state. The reaction was allowed to proceed for 2 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was distilled under reduced pressure to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 91%.

[0129] The structure of compound 15 was detected by NMR, and the results are as follows:

[0130] 1H NMR (400MHz, CDCl3) δ7.73 (ddd, J=11.2, 8.3, 1.4Hz, 2H), 7.47 (td, J=6.5, 5.8, 1.5H z,1H),7.37(dddd,J=12.6,11.0,7.4,2.3Hz,4H),7.24(dddd,J=11.9,7.6,1.4Hz,3H) ,7.17–7.10(m,5H),7.01(dd,J=7.3,2.3Hz,2H),6.96(d,J=7.8Hz,2H),6.58(s,1H) ,4.48(d,J=7.4Hz,1H),3.97(d,J=13.2Hz,1H),3.50(d,J=13.1Hz,1H),2.20(s,3H). 13 C NMR (101MHz, CDCl3) δ138.16,137.00,133.28,131.73,131.67,131.63,131.54,131.50,131.32,131.24,12 9.41,128.93,128.49,128.37,128.33,128.21,128.10,127.41,77.48,77.16,76.84,61.37,61.26,21.32.

[0131] Example 16 Synthesis of (((Hydroxy)benzylamino)(3-methylphenyl)methyl)diphenylphosphine oxide (Compound 16)

[0132] The structural formula of compound 16 is:

[0133]

[0134] The synthesis process is as follows: N-benzyl-α-(3-methylphenyl)nitrone (0.001 mol) and diphenylphosphine (0.002 mol) are added in sequence in a round-bottom flask with a volume of 10 ml, the temperature (65°C) is such that the reactants are in a molten state, the reaction is carried out for 2 hours, and the reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 90%.

[0135] The structure of compound 16 was detected by NMR, and the results are as follows:

[0136] 1H NMR (400MHz, CDCl3) δ7.85 (ddd, J=11.2, 8.3, 1.4Hz, 2H), 7.78–7.70 (m, 1H), 7.62–7. 57(m,1H),7.57–7.53(m,1H),7.53–7.49(m,2H),7.47(d,J=1.3Hz,1H),7.46–7.42(m ,2H),7.36–7.31(m,1H),7.28–7.23(m,6H),7.16–7.14(m,2H),7.07(d,J=7.6Hz,1H) ,4.61(d,J=6.9Hz,1H),4.10(d,J=13.2Hz,1H),3.65(d,J=13.2Hz,1H),2.28(s,3H). 13 CNMR (101MHz, CDCl3) δ137.76,137.01,132.72,132.69,132.41,132.35,132.29,131.6 9,131.66,131.64,131.55,131.51,131.49,131.36,131.33,131.28,130.89,130.78,1 29.42,129.36,129.15,129.13,129.09,128.97,128.81,128.75,128.50,128.44,128.38,128.32,128.12,128.03,128.01,127.43,77.48,77.16,76.84,61.55,61.44,21.50.

[0137] Example 17 Synthesis of (((Hydroxy)benzylamino)(3,4-dimethylphenyl)methyl)diphenylphosphine oxide (Compound 17)

[0138] The structural formula of compound 17 is:

[0139]

[0140] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(3,4-dimethylphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: n-hexane / ethyl acetate, 60:40) to obtain a pure product. The yield was 89%.

[0141] The structure of compound 17 was detected by nuclear magnetic resonance, and the results are as follows:

[0142] 1 H NMR(400MHz, CDCl3)δ7.88–7.82(m,2H),7.75(ddd,J=13.8,8.1,1.4Hz,1H),7.61–7.58(m,1H),7 .58–7.55(m,1H),7.51(dq,J=6.9,4.0,3.0Hz,4H),7.44(d,J=6.9Hz,1H),7.38–7.33(m,1H),7.26 (dd,J=5.1,2.0Hz,4H),7.20(d,J=8.0Hz,1H),7.15–7.13(m,1H),7.04(d,J=7.7Hz,1H),6.66(s, 1H), 4.60 (d, J = 7.5Hz, 1H), 4.11 (d, J = 13.2Hz, 1H), 3.64 (d, J = 13.2Hz, 1H), 2.22 (d, J = 6.8Hz, 6H). 13 C NMR (101MHz, CDCl3) δ137.02,136.71,136.69,136.22,132.85,132.79,132.62,132.59,13 1.57,131.54,131.51,131.49,131.39,131.36,131.29,131.20,130.79,130.68,129.72,12 9.67,129.32,129.29,129.23,129.19,129.13,128.99,128.95,128.90,128.87,128.37,128.33,128.25,128.20,128.05,127.94,127.27,126.49,71.00,61.26,61.15,19.77,19.54.

[0143] Example 18 Synthesis of (((Hydroxy)benzylamino)(4-methoxyphenyl)methyl)diphenylphosphine oxide (Compound 18)

[0144] The structural formula of compound 18 is:

[0145]

[0146] In a round-bottom flask with a volume of 25 ml, N-benzyl-α-(4-methoxyphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and water (10 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (90°C) was reacted for 4 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was extracted with 50 ml × 3 ethyl acetate for three times, the organic layer was separated and combined, the organic phase was dried with anhydrous sodium sulfate, filtered, and the filtrate was decompressed and distilled to remove the solvent to obtain the initial product. Then the initial product was purified by recrystallization (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 93%.

[0147] The structure of compound 18 was detected by NMR, and the results are as follows:

[0148] 1 H NMR (400MHz, CDCl3) δ7.79(ddd,J=11.2,6.9,1.9Hz,2H),7.53–7.49(m,1H),7.47–7.34(m,6H),7.28(d,J=1.7Hz,1H),7.24–7.16(m,5H),7. 10–7.01(m,2H),6.79–6.50(m,3H),4.53(t,J=7.5Hz,1H),4.03(dd,J=13.1,3.9Hz,1H),3.73(d,J=4.3Hz,3H),3.56(dd,J=13.1,2.6Hz,1H). 13 C NMR (101MHz, CDCl3) δ159.62,137.05,133.11,131.67,131.56,131.31,131.23,129.40,128.51,1 28.40,128.36,128.27,128.15,127.44,113.63,77.48,77.16,76.84,61.33,61.21,55.29,29.84.

[0149] Example 19 Synthesis of (((Hydroxy)benzylamino)(3-methoxyphenyl)methyl)diphenylphosphine oxide (Compound 19)

[0150] The structural formula of compound 19 is:

[0151]

[0152] The synthesis process is as follows: in a round-bottom flask with a volume of 25 ml, N-benzyl-α-(3-methoxyphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and water (10 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer. The mixture is reacted at a temperature (90° C.) for 4 hours, and the reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is extracted with 50 ml×3 ethyl acetate for three times, the organic layer is separated and combined, the organic phase is dried with anhydrous sodium sulfate, filtered, and the filtrate is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 92%.

[0153] The structure of compound 19 was detected by nuclear magnetic resonance, and the results are as follows:

[0154] 1 H NMR (400MHz, CDCl3) δ7.84–7.77(m,2H),7.69(ddd,J=13.7,8.2,1.4Hz,2H),7.54(dt,J=3.8,1.7Hz, 1H),7.51(dd,J=4.1,2.2Hz,1H),7.48–7.45(m,3H),7.41(dt,J=3.7,1.2Hz,1H),7.39(d,J=1.6Hz,1 H),7.31–7.28(m,1H),7.21(dd,J=5.2,2.1Hz,3H),7.12–7.09(m,2H),7.05–7.00(m,1H),6.98–6.94 (m,1H),6.79–6.74(m,1H),4.59(d,J=6.8Hz,1H),4.07(d,J=13.2Hz,1H),3.81(s,1H),3.70(s,3H). 13 C NMR (101MHz, CDCl3) δ159.32,132.72,132.69,131.76,131.62,131.53,131.35,131.26,130.89,130.78,129.51,129. 38,129.36,129.12,129.09,128.97,128.54,128.42,128.34,128.20,128.09,127.52,121.83,114.60,112.34,55.35.

[0155] Example 20 Synthesis of (((Hydroxy)benzylamino)(2-methoxyphenyl)methyl)diphenylphosphine oxide (Compound 20)

[0156] The structural formula of compound 20 is:

[0157]

[0158] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(2-methoxyphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 92%.

[0159] The structure of compound 20 was detected by NMR, and the results are as follows:

[0160] 1 H NMR(400MHz, CDCl3)δ8.10(d,J=7.7Hz,1H),7.93–7.86(m,2H),7.57–7.39(m,5H),7.30–7.10(m,9H),6.92(td,J=7.5,1.1Hz,1H ),6.65(dt,J=8.3,1.1Hz,1H),6.57(s,1H),5.42(d,J=6.8Hz,1H),3.95(d,J=13.5Hz,1H),3.69(d,J=13.4Hz,1H),3.60(s,3H). 13 C NMR (101MHz, CDCl3) δ156.80,156.74,137.20,133.51,132.52,131.62,131.22,131.20,131.17,131.13,130.97,130.94,130.72,130.63,129.1 2,129.10,128.89,128.12,128.00,127.66,127.45,127.34,126.81,120 .36,120.34,120.18,109.37,77.16,76.84,76.52,61.78,61.66,54.78.

[0161] Example 21 Synthesis of (((Hydroxy)benzylamino)(3,5-dimethoxyphenyl)methyl)diphenylphosphine oxide (Compound 21)

[0162] The structural formula of compound 21 is:

[0163]

[0164] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(3,5-dimethoxyphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 90%.

[0165] The structure of compound 21 was detected by nuclear magnetic resonance, and the results are as follows:

[0166] 1 H NMR (400MHz, CDCl3) δ7.86–7.77(m,2H),7.60–7.39(m,7H),7.37–7.31(m,1H),7.23(dt,J=4.9,2.4Hz,4H),7.13(dd,J=6.6,2 .9Hz,2H),6.63–6.56(m,2H),6.33(d,J=1.2Hz,1H),4.55(d,J=6.7Hz,1H),4.09(d,J=13.2Hz,1H),3.79(s,1H),3.68(s,6H). 13 CNMR(101MHz,CDCl3)δ160.36,133.63,133.11,132.68,132.12,131.77,13 1.74,131.64,131.60,131.55,131.38,131.29,130.89,130.78,130.73,12 9.47,129.38,129.13,129.09,128.96,128.54,128.42,128.34,128.21,12 8.09,127.50,109.62,109.56,100.94,77.48,77.16,76.84,55.59,55.47.

[0167] Example 22 Synthesis of (((Hydroxy)benzylamino)(4-(acetoxy)phenyl)methyl)diphenylphosphine oxide (Compound 22)

[0168] The structural formula of compound 22 is:

[0169]

[0170] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-(acetoxy)phenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60° C.) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield was 84%.

[0171] The structure of compound 22 was detected by nuclear magnetic resonance, and the results are as follows:

[0172] 1 H NMR (400MHz, CDCl3) δ7.85–7.78(m,2H),7.73–7.66(m,1H),7.54(dd,J=7.6, 1.6Hz,1H),7.48–7.43(m,4H),7.42–7.35(m,3H),7.30(dd,J=7.5,1.6Hz,1H) ,7.24–7.20(m,4H),7.10(dt,J=7.4,3.5Hz,2H),6.97(d,J=8.3Hz,2H),4.62( d,J=7.2Hz,1H),4.07(d,J=13.2Hz,1H),3.61(d,J=13.2Hz,1H),2.26(s,3H). 13 C NMR (101MHz, CDCl3) δ169.11,150.76,136.79,132.71,132.68,132.65,1 31.78,131.75,131.65,131.62,131.53,131.25,131.16,130.87,130.75 ,130.03,129.40,129.31,129.10,129.07,128.95,128.53,128.42,128. 36,128.30,128.19,127.50,121.74,121.25,77.48,77.16,76.84,21.29.

[0173] Example 23 Synthesis of (((Hydroxy)benzylamino)(4-(dimethylamino)phenyl)methyl)diphenylphosphine oxide (Compound 23)

[0174] The structural formula of compound 23 is:

[0175]

[0176] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-(dimethylamino)phenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 88%.

[0177] The structure of compound 23 was detected by nuclear magnetic resonance, and the results are as follows:

[0178] 1 H NMR (400MHz, CDCl3) δ9.44 (s, 3H), 7.57–7.51 (m, 5H), 7.30 (td, J = 7.4, 1.4Hz, 3H), 7.26 (s ,2H),7.19(dp,J=7.3,2.9Hz,7H),7.12(d,J=6.0Hz,5H),3.43(s,2H),1.30–1.22(m,2H). 13 C NMR (101MHz, CDCl3) δ134.00,131.30,131.21,130.26,128.66,128.18,128.11,127.98,77.48,77.16,76.84,42.74.

[0179] Example 24 Synthesis of (((Hydroxy)benzylamino)(4-isopropylphenyl)methyl)diphenylphosphine oxide (Compound 24)

[0180] The structural formula of compound 24 is:

[0181]

[0182] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(4-isopropylphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 95%.

[0183] The structure of compound 24 was detected by nuclear magnetic resonance, and the results are as follows:

[0184] 1H NMR (400MHz, CDCl3) δ7.82 (ddd, J=11.2, 8.3, 1.4Hz, 2H), 7.57–7.51 (m, 1H), 7 .46(ddd,J=8.5,6.6,3.1Hz,2H),7.42–7.34(m,4H),7.31–7.26(m,1H),7.24–7 .15(m,5H),7.14–7.05(m,4H),6.66(s,1H),4.59(d,J=7.0Hz,1H),4.08(d,J= 13.1Hz,1H),3.62(d,J=13.2Hz,1H),2.83(p,J=6.9Hz,1H),1.22–1.14(m,6H). 13 C NMR (101MHz, CDCl3) δ149.00,148.98,137.08,133.33,132.34,131.86,131.65,131.61,131.58,131.56,131.37,131.34,131.32,131.24,1 30.88,129.38,128.62,128.44,128.33,128.28,128.07,127.96,127 .36,126.23,77.48,77.16,76.84,61.47,61.35,33.85,23.99,23.95.

[0185] Example 25 Synthesis of (((Hydroxy)benzylamino)(1,1'-biphenylyl)methyl)diphenylphosphine oxide (Compound 25)

[0186] The structural formula of compound 25 is:

[0187]

[0188] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-(1,1'-biphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 88%.

[0189] The structure of compound 25 was detected by NMR, and the results are as follows:

[0190] 1H NMR (400MHz, CDCl3) δ7.84 (dd, J=11.2, 7.6Hz, 2H), 7.71 (dd, J=13.8, 7.4Hz, 2H), 7.63(dd,J=10.7,8.0Hz,2H),7.55(d,J=7.5Hz,3H),7.51–7.47(m,6H),7.43(d,J =7.2Hz,4H),7.36–7.33(m,1H),7.29(d,J=7.4Hz,1H),7.25–7.22(m,3H),7.13(d d,J=6.8,2.6Hz,2H),5.08(s,1H),4.12(d,J=13.0Hz,1H),3.67(d,J=13.2Hz,1H). 13 C NMR (101MHz, CDCl3) δ141.02,140.56,140.25,136.74,132.72,132.70,132.18,132. 12,131.79,131.66,131.58,131.34,131.25,130.89,130.78,129.51,129.38,129.24 ,129.12,129.09,128.99,128.97,128.88,128.56,128.44,128.38,128.27,128.16,127.95,127.55,127.18,127.14,127.11,126.83,77.48,77.16,76.84,71.31,61.60.

[0191] Example 26 Synthesis of (1-((Hydroxy)benzylamino)propyl)diphenylphosphine oxide (Compound 26).

[0192] The structural formula of compound 26 is:

[0193]

[0194] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-ethyl nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 82%.

[0195] The structure of compound 26 was detected by nuclear magnetic resonance, and the results are as follows:

[0196] 1 H NMR (400MHz, CDCl3) δ7.75(ddd,J=11.1,8.3,1.5Hz,4H),7.52–7.40(m,7H),7.21(dd,J=5.0,1.9Hz,3H),7.09–7.03(m,2H),4.25(d,J=13.2Hz,1H),3. 99(d,J=13.2Hz,1H),3.64(td,J=7.0,5.2Hz,1H),2.23(ddt,J=14.9,11.4, 7.4Hz, 1H), 1.76 (dddd, J=19.3, 9.6, 7.5, 5.2Hz, 1H), 0.92 (t, J=7.5Hz, 3H). 13 C NMR (101MHz, CDCl3) δ137.48,133.07,132.70,132.67,132.56,132.11,13 1.92,131.89,131.72,131.69,131.65,131.39,131.30,131.20,130.85,1 30.74,129.43,129.29,129.06,129.01,128.93,128.73,128.62,128.51, 128.31,127.36,66.02,65.21,61.67,61.57,17.29,17.25,13.92,13.84.

[0197] Example 27 Synthesis of (1-((Hydroxy)benzylamino)butyl)diphenylphosphine oxide (Compound 27)

[0198] The structural formula of compound 27 is:

[0199]

[0200] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-benzyl-α-propyl nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 3 hours. The reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 85%.

[0201] The structure of compound 27 was detected by nuclear magnetic resonance, and the results are as follows:

[0202] 1H NMR (400MHz, CDCl3) δ7.80–7.72(m,4H),7.51–7.47(m,2H),7.44(dt,J=8.1,3.3Hz,4H ),7.38(s,1H),7.20(dd,J=5.0,2.0Hz,2H),7.05(dd,J=6.7,2.8Hz,2H),6.40(s,1H),4 .24(d,J=13.2Hz,1H),3.97(d,J=13.2Hz,1H),3.73(td,J=7.1,5.1Hz,1H),2.26–2.10( m,1H),1.73–1.60(m,1H),1.51–1.41(m,1H),1.22–1.11(m,1H),0.79(t,J=7.3Hz,3H). 13 C NMR (101MHz, CDCl3) δ137.46,133.04,132.69,132.66,132.50,132.08,131.93,131.90, 131.71,131.68,131.59,131.43,131.34,131.28,131.19,130.85,130.74,129.38,129.2 8,129.06,129.00,128.98,128.93,128.70,128.61,128.59,128.50,128.29,127.35,77.48,77.16,76.84,64.24,63.43,61.66,61.57,25.91,25.87,22.26,22.18,14.20,14.07.

[0203] Example 28 Synthesis of (1-((Hydroxy)benzylamino)isobutyl)diphenylphosphine oxide (Compound 28)

[0204] The structural formula of compound 28 is:

[0205]

[0206] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-isopropyl nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 83%.

[0207] The structure of compound 28 was detected by nuclear magnetic resonance, and the results are as follows:

[0208] 1 H NMR(400MHz, CDCl3) δ7.80(dddd,J=11.1,8.4,3.1,1.5Hz,4H),7.62–7.34(m,7H),7.19(dd,J=5.1,2.0Hz,3H),7.04–6.93(m,2H),6.73(s,1H) ,4.24(d,J=13.2Hz,1H), 4.09(d,J=13.2Hz,1H), 3.63(dd,J=7.9,4.6Hz,1H), 2.45(dpd,J=11.4,6.9,4.6Hz,1H), 1.06(dd,J=24.9,6.9Hz,6H). 13 C NMR (101MHz, CDCl3) δ137.54,134.71,133.78,132.89,131.70,131.67,131.48, 131.45,131.30,131.20,131.05,130.96,130.79,130.67,129.14,129.05,128.9 9,128.93,128.86,128.62,128.58,128.51,128.46,128.19,127.25,77.38,77.06,76.74,69.12,68.40,62.61,62.54,28.12,28.06,22.23,22.16,21.82,21.78.

[0209] Example 29 Synthesis of (1-((Hydroxy)benzylamino)pentyl)diphenylphosphine oxide (Compound 29)

[0210] The structural formula of compound 29 is:

[0211]

[0212] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-benzyl-α-butyl nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 3 hours. The reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield is 88%.

[0213] The structure of compound 29 was detected by nuclear magnetic resonance, and the results are as follows:

[0214] 1 H NMR(400MHz, CDCl3)δ7.75(tt,J=8.5,2.2Hz,4H),7.51–7.47(m,2H),7.43(dq,J=7.7,3.7Hz, 4H),7.37(s,1H),7.20(dd,J=4.9,2.0Hz,3H),7.07–7.04(m,1H),6.46(s,1H),4.24(d,J=13.1 Hz,1H),3.96(d,J=13.2Hz,1H),3.70(q,J=6.5Hz,1H),2.20(dtt,J=16.6,11.4,5.7Hz,1H),1. 78–1.61(m,1H),1.43(ddt,J=13.9,8.7,5.3Hz,1H),1.24–1.05(m,3H),0.75(t,J=7.2Hz,3H). 13 C NMR (101MHz, CDCl3) δ137.47,132.99,132.66,132.63,132.49,132.03,131.88,131.85,131.66, 131.63,131.57,131.41,131.33,131.27,131.18,130.81,130.70,129.35,129.27,129.02,128. 96,128.93,128.90,128.65,128.61,128.57,128.54,128.49,128.45,128.25,127.30,77.48,77.16,76.84,64.39,63.58,61.58,61.48,31.20,31.12,27.65,26.55,23.28,23.24,22.70,13.80.

[0215] Example 30 Synthesis of (1-((Hydroxy)benzylamino)-3-methylbutyl)diphenylphosphine oxide (Compound 30)

[0216] The structural formula of compound 30 is:

[0217]

[0218] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-benzyl-α-isobutyl nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 3 hours. The reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield is 93%.

[0219] The structure of compound 30 was detected by NMR, and the results are as follows:

[0220] 1 H NMR (400MHz, CDCl3) δ7.82–7.75 (m, 3H), 7.69 (ddd, J = 13.7, 8.2, 1.4Hz, 1H), 7.57–7. 43(m,7H),7.38(s,1H),7.19(dd,J=5.0,1.9Hz,2H),7.10–7.01(m,2H),4.25(d,J=13 .3Hz,1H),3.99(d,J=13.3Hz,1H),3.85(td,J=7.6,4.9Hz,1H),2.13(dddd,J=14.1,1 0.8,7.8,5.8Hz,1H),1.65–1.39(m,2H),0.84(d,J=6.5Hz,3H),0.71(d,J=6.5Hz,3H). 13 CNMR (101MHz, CDCl3) δ137.61,133.14,133.06,132.68,132.65,132.48,132.18,131.94,131 .91,131.76,131.74,131.57,131.46,131.38,131.29,130.85,130.74,129.35,129.19,129. 05,129.01,128.97,128.92,128.69,128.66,128.58,128.54,128.26,127.30,77.48,77.16,76.84,62.62,61.83,61.61,61.52,32.99,32.95,26.25,26.17,26.07,23.02,22.68,21.93.

[0221] Example 31 Synthesis of (1-((Hydroxy)benzylamino)phenylpropyl)diphenylphosphine oxide (Compound 31)

[0222] The structural formula of compound 31 is:

[0223]

[0224] In a round-bottom flask with a volume of 10 ml, N-benzyl-α-phenethyl nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60° C.) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by a pulping method (solvent: petroleum ether or n-hexane) to obtain a pure product. The yield was 82%.

[0225] The structure of compound 31 was detected by nuclear magnetic resonance, and the results are as follows:

[0226] 1 H NMR (400MHz, CDCl3) δ7.76–7.64(m,5H),7.55–7.52(m,2H),7.50–7.42(m, 4H),7.29(s,1H),7.26–7.19(m,5H),7.07–7.01(m,2H),6.97(d,J=1.8Hz,1 H),6.68–6.36(m,1H),4.27(d,J=13.1Hz,1H),4.00(d,J=13.1Hz,1H),3.81 –3.72(m,1H),2.85(t,J=4.2Hz,1H),2.65–2.54(m,2H),2.09–1.96(m,1H). 13 C NMR (101MHz, CDCl3) δ132.95,132.70,132.04,131.80,131.42,131.35,131.32,131.26,130.90,130.79,129.44,129.10,129.03,1 28.97,128.84,128.75,128.72,128.66,128.59,128.42,127.48,126.41,126.19,62.76,61.87,61.78,34.22,34.14,26.09,26.04.

[0227] Example 32 Synthesis of ((hydroxy(methyl)amino)(phenyl)methyl)diphenylphosphine oxide (Compound 32)

[0228] The structural formula of compound 32 is:

[0229]

[0230] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-methyl-α-phenylnitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 3 hours. The reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 88%.

[0231] The structure of compound 32 was detected by nuclear magnetic resonance, and the results are as follows:

[0232] 1 H NMR (400MHz, CDCl3) δ7.97–7.86(m,2H),7.54–7.41(m,5H),7.31(ddd,J=8.8,7.0,1.6Hz,3H),7.25–7.05(m,6H),4.61(d,J=5.3Hz,1H),2.59(s,3H). 13 C NMR (101MHz, CDCl3) δ133.39,132.41,132.12,131.84,131.81,131.68,131.62,131.56,131.53,131.49, 131.48,131.26,131.20,130.70,128.63,128.52,128.34,128.33,128.18,128.14,128.02,46.75,46.64.

[0233] Example 33 Synthesis of ((hydroxy(methyl)amino)(4-methylphenyl)methyl)diphenylphosphine oxide (Compound 33)

[0234] The structural formula of compound 33 is:

[0235]

[0236] In a round-bottom flask with a volume of 10 ml, N-methyl-α-(4-methylphenyl)nitrone (0.001 mol), diphenylphosphine (0.0015 mol), and n-hexane (5 ml) were added in sequence, and a magnetic stirrer was placed on the magnetic stirrer and stirred at 500 rpm. The temperature (60°C) was reacted for 3 hours, and the reaction was monitored by TLC. When no nitrone compound remained, the mixed solution was decompressed and distilled to remove the solvent to obtain the initial product. The initial product was then purified by recrystallization (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield was 92%.

[0237] The structure of compound 33 was detected by nuclear magnetic resonance, and the results are as follows:

[0238] 1 H NMR(400MHz, CDCl3)δ7.88(ddd,J=11.1,8.2,1.5Hz,2H),7.55–7.45(m,5H),7.37–7.32(m,1H),7.25(d,J=5.7H z,2H),7.21–7.16(m,2H),6.98(d,J=7.8Hz,2H),6.76(s,1H),4.53(d,J=5.9Hz,1H),2.55(s,3H),2.25(s,3H). 13 C NMR (101MHz, CDCl3) δ131.66,131.64,131.57,131.24,128.92,128.65,128.53,128.18,128.07,77.48,77.16,76.84,46.55,46.43,21.29.

[0239] Example 34 Synthesis of (((Hydroxy)benzylamino)(phenyl)methyl)(3,5-dimethylphenyl)phosphine oxide (Compound 34)

[0240] The structural formula of compound 34 is:

[0241]

[0242] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, N-benzyl-α-phenylnitrone (0.001 mol), 3,5-dimethylphenylphosphine (0.0015 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer. The mixture is reacted at a temperature (60° C.) for 3 hours, and the reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 75%.

[0243] The structure of compound 34 was detected by NMR, and the results are as follows:

[0244] 1H NMR(400MHz, CDCl3) δ7.30(dddd,J=17.2,7.0,3.4,2.0Hz,5H),7.15–7.10(m,6H),7.07–6.98(m,3H),6.86(dd,J=11.4,1 .6Hz,2H),6.78(s,1H),4.41(d,J=8.0Hz,1H),3.94(d,J=13.1Hz,1H),3.49(d,J=13.2Hz,1H),2.24(s,6H),2.01(s,6H). 13 C NMR (101MHz, CDCl3) δ138.15,138.03,137.76,137.64,136.95,133.54,133.51,133.27,131.99,131.93,129.45,129.38,129.17 ,129.12,129.09,128.98,128.89,128.75,128.59,128.35,128.28,128.24,128.03,127.45,77.48,77.16,76.84,21.53,21.24.

[0245] Example 35 Synthesis of (2-hydroxy-1,2,3,4-tetrahydroisoquinolin-1-yl)diphenylphosphine oxide (Compound 35)

[0246] The structural formula of compound 35 is:

[0247]

[0248] The synthesis process is as follows: 3,4-dihydroisoquinoline-2-oxide (0.001 mol), diphenylphosphine (0.0012 mol), and n-hexane (5 ml) are added to a round-bottom flask with a volume of 10 ml in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer. The mixture is reacted at a temperature (60° C.) for 5 hours, and the reaction is monitored by TLC. When no nitrone compounds remain, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 85%.

[0249] The structure of compound 35 was detected by nuclear magnetic resonance, and the results are as follows:

[0250] 1H NMR (500MHz, CDCl3) δ7.87–7.78(m,4H),7.57–7.45(m,6H),7.24–7.14(m,2H),7.12(d d,J=4.8,1.2Hz,2H),4.60(p,J=6.0Hz,1H),4.40(ddd,J=11.5,6.0,1.0Hz,1H),3.99( d,J=6.4Hz,1H),2.99(dddd,J=14.8,8.0,5.7,1.1Hz,1H),2.77(dddd,J=14.8,7.9,5. 7,0.9Hz,1H),2.05(ddt,J=13.7,7.9,5.7Hz,1H),1.87(ddt,J=13.6,8.1,5.7Hz,1H). 13 C NMR (125MHz, CDCl3) δ134.88,133.46,132.56,131.76,131.30,129.35,128.59,127.21,126.92,126.68,70.81,48.93,28.60,27.28.

[0251] Example 36 Synthesis of ((2R,3S,4R)-2,3-bis(benzyloxy)-4-((benzyloxy)methyl)-5-hydroxycyclopentyl)diphenyl oxide (Compound 36)

[0252] The structural formula of compound 36 is:

[0253]

[0254] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, (2S, 3S, 4S)-3, 4-bis (benzyloxy)-2- ((benzyloxy) methyl) -3, 4-dihydro-2H-pyrrole 1-oxide (0.001 mol), diphenylphosphine (0.0012 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 5 hours, and the reaction is monitored by TLC. When no nitrone compounds remain, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 88%.

[0255] The structure of compound 36 was detected by NMR, and the results are as follows:

[0256] 1H NMR(500MHz, CDCl3)δ7.87(ddt,J=13.3,6.8,1.4Hz,4H),7.56–7.48(m,2H),7.46(tdd,J=8.0,4.0,1.0H z,4H),7.34(tddd,J=5.0,3.3,2.3,1.2Hz,4H),7.34–7.24(m,11H),4.73(dd,J=6.6,5.9Hz,1H),4.62(d dt,J=12.1,6.0,0.9Hz,2H),4.56–4.49(m,2H),4.49–4.38(m,3H),4.29(dd,J=5.9,4.2Hz,1H),4.07(dd ,J=11.4,6.6Hz,1H),3.83(dd,J=10.6,4.6Hz,1H),3.69(dd,J=10.5,4.7Hz,1H),3.31(q,J=4.5Hz,1H). 13 C NMR (125MHz, CDCl3) δ137.82,137.59,137.42,131.79,130.98,130.72,128.62,128.43,128.41,128.40,128. 22,128.13,128.10,128.08,128.07,127.99,127.95,81.64,81.29,73.30,72.87,72.39,67.00,61.80,58.93.

[0257] Example 37 ((3R, 4S, 5S)-3,4-bis(benzyloxy)-5-((S)-1,2-bis(benzyloxy)ethyl)-1-hydroxypyrrolidin-2-yl)diphenylphosphine oxide

[0258] The structural formula of compound 37 is:

[0259]

[0260] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, (2S, 3S, 4S)-3, 4-bis (benzyloxy) -2- ((S) -1, 2-bis (benzyloxy) ethyl) -3, 4-dihydro-2H-pyrrole-1-oxide (0.001 mol), diphenylphosphine (0.0012 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 8 hours, and the reaction is monitored by TLC. When no nitrone compounds remain, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 82%.

[0261] The structure of compound 37 was detected by nuclear magnetic resonance, and the results are as follows:

[0262] 1 H NMR(500MHz, CDCl3)δ7.90–7.81(m,4H),7.55–7.48(m,2H),7.46(tdd,J=7.9,3.9,1.0Hz,4H),7.38–7.24 (m,20H),4.93(dd,J=6.6,5.9Hz,1H),4.77(s,1H),4.72(dt,J=12.1,1.1Hz,1H),4.62(dt,J=12.1,1.1Hz ,1H),4.58–4.50(m,2H),4.52–4.45(m,2H),4.42(ddt,J=15.9,12.1,1.0Hz,2H),4.25(t,J=5.9Hz,1H),4 .07(dd,J=11.5,6.6Hz,1H),3.80–3.70(m,2H),3.56(dd,J=11.0,5.9Hz,1H),3.23(dd,J=6.2,5.3Hz,1H). 13 C NMR (125MHz, CDCl3) δ137.79,137.76,137.50,137.43,131.74,130.94,130.67,128.63,128.46,128.45,128.43,128.41,128.39,128.27, 128.24,128.21,128.18,128.15,128.14,128.07,128.01,128.00,81 .98,80.73,74.53,73.60,72.94,72.50,71.18,70.95,62.88,61.85.

[0263] Example 38 ((3R, 4S, 5R)-3,4-bis(benzyloxy)-5-((S)-1,2-bis(benzyloxy)ethyl)-1-hydroxypyrrolidin-2-yl)diphenylphosphine oxide

[0264] The structural formula of compound 38 is:

[0265]

[0266] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, (2R, 3S, 4S)-3,4-bis(benzyloxy)-2-((S)-1,2-bis(benzyloxy)ethyl)-3,4-dihydro-2H-pyrrole-1-oxide (0.001 mol), diphenylphosphine (0.0012 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is added, and the mixture is stirred at 500 rpm on a magnetic stirrer. The mixture is reacted at a temperature (60° C.) for 8 hours, and the reaction is monitored by TLC. When no nitrone compounds remain, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 80%.

[0267] The structure of compound 38 was detected by NMR, and the results are as follows:

[0268] 1 H NMR(500MHz, CDCl3)δ7.89(ddt,J=13.2,6.8,1.4Hz,4H),7.55–7.48(m,2H),7.46(tdd,J=7.9,3.9 ,1.1Hz,4H),7.38–7.24(m,20H),4.98(dd,J=6.6,5.9Hz,1H),4.62(dt,J=12.0,1.1Hz,1H),4.58– 4.47(m,4H),4.51–4.37(m,3H),4.35(dt,J=12.1,1.0Hz,1H),4.16(dd,J=5.8,5.1Hz,1H),4.07(d d,J=11.6,6.6Hz,1H),3.80–3.69(m,2H),3.49(dd,J=11.3,5.4Hz,1H),3.27(t,J=5.2Hz,1H).13C NMR (125MHz, CDCl3) δ137.79,137.76,137.50,137.43,131.74,130.94,130.67,128.63,128.46,128.45,128.43,128.41,128.39,128.27, 128.24,128.21,128.18,128.15,128.14,128.07,128.01,128.00,81 .98,80.73,74.53,73.60,72.94,72.50,71.18,70.95,62.88,61.85.

[0269] Example 38 ((3R,4S,5S,6R)-3,4,5-tri(benzyloxy)-6-((benzyloxy)methyl)-1-hydroxypiperidin-2-yl)diphenylphosphine oxide

[0270] The structural formula of compound 39 is:

[0271]

[0272] The synthesis process is as follows: in a round-bottom flask with a volume of 10 ml, (2R, 3S, 4S, 5S)-3, 4, 5-tris (benzyloxy)-2- ((benzyloxy) methyl) -2, 3, 4, 5-tetrahydropyridine-1-oxide (0.001 mol), diphenylphosphine (0.0012 mol), and n-hexane (5 ml) are added in sequence, a magnetic stirrer is placed, and the mixture is stirred at 500 rpm on a magnetic stirrer, and the reaction temperature (60° C.) is maintained for 5 hours, and the reaction is monitored by TLC. When no nitrone compound remains, the mixed solution is decompressed and distilled to remove the solvent to obtain the initial product. The initial product is then purified by a recrystallization method (solvent: n-hexane / ethyl acetate, 80:20) to obtain a pure product. The yield is 85%.

[0273] The structure of compound 39 was detected by nuclear magnetic resonance, and the results are as follows:

[0274] 1 H NMR(500MHz, CDCl3))δ7.86–7.77(m,5H),7.55–7.48(m,2H),7.45(tdd,J=7.8,3.9,1.0Hz,4H),7.40–7.32 (m,6H),7.35–7.24(m,15H),4.80(ddt,J=11.9,3.5,1.0Hz,2H),4.63(dt,J=12.1,1.0Hz,2H),4.51(dt,J= 12.1,0.9Hz,1H),4.48–4.36(m,4H),4.04(dd,J=11.5,6.6Hz,1H),3.99(dd,J=7.6,5.2Hz,1H),3.86(dd,J =5.2,3.6Hz,1H),3.80(dd,J=10.5,6.3Hz,1H),3.74(dd,J=10.5,6.3Hz,1H),3.16(td,J=6.3,3.7Hz,1H). 13CNMR(125MHz, CDCl3))δ138.39,137.73,137.51,137.43,131.74,130.69,130.67,128.63,128.46,128.45,128.43,128.41,128.39,128.27 ,128.24,128.21,128.18,128.17,128.15,128.07,128.01,128.00,7 6.61,75.83,75.42,73.24,72.40,71.92,71.80,71.75,64.30,57.25.

[0275] Embodiment 40

[0276] The in vitro anti-tumor activity test and the cytotoxicity experiment on normal cells of the synthetic compound of the present invention are carried out.

[0277] Experimental principle: The in vitro test was performed using the MTT reduction method. Camptothecin was used as a positive control.

[0278] Cell lines: human lung adenocarcinoma cells (A549), human breast cancer cells (MCF-7), mouse lung epithelial cells (TC-1).

[0279] Experimental methods:

[0280] The concentration was prepared to be 1×10 5 μg / mL cell suspension was added to a 96-well plate, 100 μL per well, and incubated in a 37°C, 5% CO2 incubator for 24 h.

[0281] Add the test substances at different concentrations to the cultured tumor cells and normal cells in a 96-well plate, continue culturing for 24 hours, and observe under an inverted microscope.

[0282] The culture medium was discarded, and 100 μL of 0.05% MTT application solution was added to each well and cultured for 4 h.

[0283] The culture medium was discarded, 100 μL DMSO was added to each well, and the cells were shaken for 5 min to dissolve the formazan crystals. The cell absorbance (OD value) was measured at 490 nm.

[0284] The experimental data processing method is as follows:

[0285] The absorbance of the cells in the wells without drug addition was taken as the absorbance of the blank control group (OD value), and the calculation formula was as follows:

[0286] Inhibition rate (%) = (blank control group OD average - sample group OD average) / blank control OD average × 100%,

[0287] The concentration and time-growth inhibition rate curves were obtained by plotting the growth inhibition rates at different times and different doses, and the GraphPad Prism 9.0 software was used to plot the curves, and the IC50 of the half-maximal inhibition concentration of the target compound on the two tumor cells was calculated using the software. See the table below.

[0288]

[0289] From the results in the above table, it can be seen that the compounds of the present invention have a certain inhibitory effect on A549 / MCF-7 tumor cells, and they have no obvious toxicity to normal cells TC-1, indicating that the compounds of the present invention have potential medicinal value and are expected to be used in the preparation of various anticancer drugs.

[0290] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.

Claims

1. A method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone, characterized in that: Using a nitrone as shown in formula (2) and a diarylphosphine oxide compound as shown in formula (3) as raw materials, reacting under heating conditions to obtain an α-(hydroxyamino)diarylphosphine oxide as shown in formula (1), wherein the heating conditions are 60-90° C. and the reaction time is 1-3 hours. Wherein, the α-(hydroxyamino)diarylphosphine oxide represented by formula (1) is selected from one of the following compounds:

2. The method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone according to claim 1, characterized in that: Calculated by the molar ratio, the ratio of nitrone to diarylphosphine oxide is 1:1-2.

3. The method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone according to claim 1, characterized in that: Using nitrone and diarylphosphine oxide as raw materials and water or n-hexane as solvent; The amount of water or n-hexane is 50-100 times the amount of nitrone.

4. The method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone according to claim 1, characterized in that: After the α-(hydroxyamino)diarylphosphine oxide represented by formula (1) is obtained, it is purified. The purification steps are: removing the solvent, purifying by recrystallization or pulping to obtain a pure product.

5. The method for preparing α-(hydroxyamino)diarylphosphine oxide from nitrone according to claim 4, characterized in that: The steps of recrystallization are: first dissolving the product with ethyl acetate, then precipitating the product with n-hexane, and filtering to obtain a pure product; or The steps of beating are: firstly, adding n-hexane to the product, stirring rapidly to dissolve the impurities, and then filtering to obtain a pure product.

6. Use of the α-(hydroxyamino)diarylphosphine oxide prepared by the method of claim 1 in the preparation of anti-tumor drugs, wherein the tumor is lung cancer or breast cancer.